MIRIAD Biobank for IBD Research

Condition: Inflammatory bowel disease


Key Inclusion Criteria

  • Diagnosis of IBD
  • Family members of patients participating in the M.I.R.I.A.D. Biobank
  • Control subjects without IBD

Key Exclusion Criteria

  • Individuals for whom obtaining specimens would pose more than minimal risk

Full Study Name

M.I.R.I.A.D. Biobank - Material and Information Resources for Inflammatory And Digestive Diseases - F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute (IRB no. 3358)


The purpose of the M.I.R.I.A.D. Biobank is to advance the understanding of inflammatory bowel diseases (IBD) and other inflammatory disorders. The Biobank collects specimens for immediate use in research studies and maintains specimens for future use. It also gathers information about donated samples from participants’ medical records. Specimens and health information are used in M.I.R.I.A.D. Biobank-supported investigations to improve the diagnosis and treatment of disease. Current and future uses of specimens may include genome sequencing, stem cell research and/or creation of cell lines.

Please see additional information regarding this study.

Principal Investigator

Stephan Targan, MD

MIRIAD Biobank Offices
8700 Beverly Blvd, Suite D4063,
Los Angeles, CA 90048
Phone: 310-423-3550
Email: MIRIAD.IBDBiobank@cshs.org